Predicting the effects of long-term medical treatment in acromegaly. At what cost? For what benefits?

被引：8
作者：
Chanson, P [1 ]
机构：
[1] UNIV PARIS 11,LE KREMLIN BICETR,FRANCE
来源：
EUROPEAN JOURNAL OF ENDOCRINOLOGY | 1997年 / 136卷 / 04期
关键词：
D O I：
10.1530/eje.0.1360359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 361
页数：3
相关论文
共 18 条
  • [1] SOMATOSTATIN ANALOG SANDOSTATIN AND INHIBITION OF TUMOR-GROWTH IN PATIENTS WITH METASTATIC ENDOCRINE GASTROENTEROPANCREATIC TUMORS
    ARNOLD, R
    NEUHAUS, C
    BENNING, R
    SCHWERK, WB
    TRAUTMANN, ME
    JOSEPH, K
    BRUNS, C
    [J]. WORLD JOURNAL OF SURGERY, 1993, 17 (04) : 511 - 519
  • [2] BERTHERAT J, 1993, J CLIN ENDOCR METAB, V77, P1577, DOI 10.1210/jc.77.6.1577
  • [3] Prediction of efficacy of octreotide therapy in patients with acromegaly
    Colao, A
    Ferone, D
    Lastoria, S
    Marzullo, P
    Cerbone, G
    DiSarno, A
    Longobardi, S
    Merola, B
    Salvatore, M
    Lombardi, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) : 2356 - 2362
  • [4] CLINICALLY NONFUNCTIONING PITUITARY-ADENOMA AND OCTREOTIDE RESPONSE TO LONG-TERM HIGH-DOSE TREATMENT, AND STUDIES INVITRO
    DEBRUIN, TWA
    KWEKKEBOOM, DJ
    VANTVERLAAT, JW
    REUBI, JC
    KRENNING, EP
    LAMBERTS, SWJ
    CROUGHS, RJM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (05) : 1310 - 1317
  • [5] SOMATOSTATIN RECEPTOR IMAGING IN NONFUNCTIONING PITUITARY-ADENOMAS - VALUE OF AN UPTAKE INDEX
    DUET, M
    MUNDLER, O
    AJZENBERG, C
    BEROLATTI, B
    CHEDIN, P
    DURANTEAU, L
    WARNET, A
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (07): : 647 - 650
  • [6] INVIVO DETECTION OF SOMATOSTATIN RECEPTORS IN PATIENTS WITH FUNCTIONLESS PITUITARY-ADENOMAS BY MEANS OF A RADIOIODINATED ANALOG OF SOMATOSTATIN ([I-123]SDZ 204-090)
    FAGLIA, G
    BAZZONI, N
    SPADA, A
    AROSIO, M
    AMBROSI, B
    SPINELLI, F
    SARA, R
    BONINO, C
    LUNGHI, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (04) : 850 - 856
  • [7] Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: Six-month report on an Italian multicenter study
    Giusti, M
    Gussoni, G
    Cuttica, CM
    Giordano, G
    Camanni, F
    Ciccarelli, E
    Dallabonzana, D
    Strada, S
    Delitala, G
    Porcu, L
    Faglia, G
    Arosio, M
    Liuzzi, A
    Ghiggi, MR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) : 2089 - 2097
  • [8] [IN-111-DTPA-D-PHE(1)]OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH CARCINOID-TUMORS - THE PREDICTIVE VALUE FOR SOMATOSTATIN ANALOG TREATMENT
    JANSON, ET
    WESTLIN, JE
    ERIKSSON, B
    AHLSTROM, H
    NILSSON, S
    OBERG, K
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (06) : 577 - 581
  • [9] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]- AND [I-123-TYR(3)]-OCTREOTIDE - THE ROTTERDAM EXPERIENCE WITH MORE THAN 1000 PATIENTS
    KRENNING, EP
    KWEKKEBOOM, DJ
    BAKKER, WH
    BREEMAN, WAP
    KOOIJ, PPM
    OEI, HY
    VANHAGEN, M
    POSTEMA, PTE
    DEJONG, M
    REUBI, JC
    VISSER, TJ
    REIJS, AEM
    HOFLAND, LJ
    KOPER, JW
    LAMBERTS, SWJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1993, 20 (08): : 716 - 731
  • [10] OCTREOTIDE AND RELATED SOMATOSTATIN ANALOGS IN THE DIAGNOSIS AND TREATMENT OF PITUITARY DISEASE AND SOMATOSTATIN RECEPTOR SCINTIGRAPHY
    LAMBERTS, SWJ
    HOFLAND, LJ
    DEHERDER, WW
    KWEKKEBOOM, DJ
    REUBI, JC
    KRENNING, EP
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (01) : 27 - 55
12